Renal handling of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in rabbits in comparison with meropenem

References

• Arita T, Hori R, Owada E, Takahashi K. Transformation and excretion of drugs in biological systems. I. Renal excretion mechanisms of sulfonamides. Chemical and Pharmaceutical Bulletin 1969; 17: 2526–2532
   PubMed Web of Science ®Google Scholar
• Bahn A, Knabe M, Hagos Y, Rodiger M, Godehardt S, Neufeld DS, Evans KK, Burckhardt G, Wright SH. Interaction of the metal chelator 2,3-dimercapto-1-propanesulfonate with rabbit multispecific organic transporter 1 (rbOAT1). Molecular Pharmacology 2002; 62: 1128–1136
   PubMedGoogle Scholar
• Bax RP, Bastain W, Featherstone A, Wilkinson DM, Hutchison M, Haworth SJ. The pharmacokinetics of meropenem in volunteers. Journal of Antimicrobial Chemotherapy 1989; 24(Suppl. A)311–320
   PubMedGoogle Scholar
• Birnbaum J, Kahan FM, Kropp H, MacDonald JS. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. American Journal of Medicine 1985; 78(Suppl. 6A)3–21
   PubMedGoogle Scholar
• Bonfiglio G, Russo G, Nicoletti G. Recent developments in carbapenems. Expert Opinion on Investigational Drugs 2002; 11: 529–544
   PubMed Web of Science ®Google Scholar
• Brown GR. Cephalosporin–probenecid drug interactions. Clinical Pharmacokinetics 1993; 24: 289–300
   PubMed Web of Science ®Google Scholar
• Burckhardt BC, Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Reviews of Physiology, Biochemistry and Pharmacology 2003; 146: 95–158
   PubMed Web of Science ®Google Scholar
• Burman LA, Nilsson-Ehle I, Hutchison M, Haworth SJ, Norrby SR. Pharmacokinetics of meropenem and its metabolite ICI213,689 in healthy subjects with known renal metabolism of imipenem. Journal of Antimicrobial Chemotherapy 1991; 27: 219–224
   PubMed Web of Science ®Google Scholar
• Craig WA. The pharmacology of meropenem, a new carbapenem antibiotic. Clinical Infectious Diseases 1997; 24(Suppl. 2)S266–S275
   Google Scholar
• Craig WA. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 1998; 26: 1–10
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharmaceutical Research 1993; 10: 1093–1095
   PubMed Web of Science ®Google Scholar
• Dische Z, Borenfreund E. A new spectrophotometric method for the detection and determination of keto sugars and trioses. Journal of Biological Chemistry 1951; 192: 583–587
   PubMed Web of Science ®Google Scholar
• Drusano GL. An overview of the pharmacology of imipenem/cilastatin. Journal of Antimicrobial Chemotherapy 1986; 18(Suppl. E)79–92
   PubMedGoogle Scholar
• Drusano GL. Prevention of resistance: A goal for dose selection for antimicrobial agents. Clinical Infectious Diseases 2003; 36(Suppl. 1)S42–S50
   PubMed Web of Science ®Google Scholar
• Drusano GL, Standiford HC. Pharmacokinetic profile of imipenem/colastatin in normal volunteers. American Journal of Medicine 1985; 78(Suppl. 6A)47–53
   PubMedGoogle Scholar
• Inui K, Masuda S, Saito H. Cellular and molecular aspects of drug transport in the kidney. Kidney International 2000; 58: 944–958
   PubMed Web of Science ®Google Scholar
• Kamiya A, Okumura K, Hori R. Quantitative investigation on renal handling of drugs in rabbits, dogs, and humans. Journal of Pharmaceutical Sciences 1983; 72: 440–443
   PubMed Web of Science ®Google Scholar
• Kawamoto I. 1β-Methylcarbapenem antibiotics. Drugs Future 1998; 23: 181–189
   Google Scholar
• Kawamoto I, Shimoji Y, Kanno O, Kojima K, Ishikawa K, Matsuyama E, Ashida Y, Shibayama T, Fukuoka T, Ohya S. Synthesis and structure–activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety. Journal of Antibiotics 2003; 56: 565–579
   PubMed Web of Science ®Google Scholar
• Koga T, Abe T, Inoue H, Takenouchi T, Kitayama A, Yoshida T, Masuda N, Sugihara C, Kakuta M, Nakagawa M, Shibayama T, Matsushita Y, Hirota T, Ohya S, Utsui Y, Fukuoka T, Kuwahara S. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem. Antimicrobial Agents and Chemotherapy 2005; 49: 3239–3250
   PubMed Web of Science ®Google Scholar
• Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa A, Inui K. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. Journal of the American Society of Nephrology 2002; 13: 866–874
   PubMed Web of Science ®Google Scholar
• Murer H, Hernando N, Forster I, Biber J. Proximal tubular phosphate reabsorption: Molecular mechanisms. Physiological Reviews 2000; 80: 1373–1409
   PubMed Web of Science ®Google Scholar
• Naganuma H, Hirouchi Y, Kawahara Y, Inui K, Tanigawara Y, Yasuhara M, Hori R, Kuwahara S. Nephroprotective effect and its mechanism of betamipron (2) Relationships of renal excretion. Chemotherapy (Tokyo) 1991; 39(Suppl. 3)178–189
   Google Scholar
• Rennecke JT, Hirota T, Shibayama T, Matsushita Y, Kuwahara S, Puchler K, Ruhland A, Drewelow B (2002) Safety, tolerability, and pharmacokinetics (PK) of CS-023, a new parenteral carbapenem, in healthy male volunteers. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San DiegoCA, USA, 27–30 September, 2002. American Society for Microbiology, Washington, DC, F-327
   Google Scholar
• Schaub TP, Kartenbeck J, Konig J, Spring H, Dorsam J, Staehler G, Storkel S, Thon WF, Keppler D. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. Journal of the American Society of Nephrology 1999; 10: 1159–1169
   PubMed Web of Science ®Google Scholar
• Shibayama T, Matsushita Y, Kikuchi N, Kawai K, Hirota T, Kuwahara S (2000) R-115685, a novel parenteral Carbapenem: Pharmacokinetics and metabolism in laboratory animals. 40th Interscience Conference on Antibacterial Agents and Chemotherapy, TorontoCanada, 17–20 September, 2000. American Society for Microbiology, Washington, DC, F-1233
   Google Scholar
• Sumita Y, Nouda H, Toda E, Kohzuki T, Kato M, Okuda T, Fukasawa M. Pharmacokinetics of meropenem, a new carbapenem antibiotic, parenterally administered to laboratory animals. Chemotherapy (Tokyo) 1992; 40(Suppl. 1)S123–S130
   Google Scholar
• Takahagi H, Hirota T, Matsushita Y, Muramatsu S, Tanaka M, Matsuo E. In vitro dehydropeptidase-I activity and its hydrolytic activity of panipenem in several tissues in animal species and their influence on the disposition of panipenem in vivo. Chemotherapy (Tokyo) 1991; 39(Suppl. 3)236–241
   Google Scholar
• Takeda M, Babu E, Narikawa S, Endou H. Interaction of human organic transporters with various cephalosporin antibiotics. European Journal of Pharmacology 2002a; 438: 137–142
   PubMed Web of Science ®Google Scholar
• Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. Journal of Pharmacology and Experimental Therapeutics 2002b; 302: 666–671
   PubMed Web of Science ®Google Scholar
• Takeda M, Narikawa S, Hosoyamada M, Cha SH, Sekine T, Endou H. Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. European Journal of Pharmacology 2001; 419: 113–120
   PubMed Web of Science ®Google Scholar
• Thomson KS, Moland ES. CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 2004; 54: 557–562
   PubMed Web of Science ®Google Scholar
• Ueo H, Motohashi H, Katsura T, Inui K. Human organic transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochemical Pharmacology 2005; 70: 1104–1113
   PubMed Web of Science ®Google Scholar
• Wong SL, Hedaya MA, Sawchuk RJ. Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration. Pharmaceutical Research 1992; 9: 228–235
   PubMedGoogle Scholar
• Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiological Reviews 2003; 84: 987–1049
   Google Scholar
• Zhang X, Groves CE, Bahn A, Barendt WM, Prado MD, Rodiger M, Chatsudthipong V, Burckhardt G, Wright SH. Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule. American Journal of Physiology. Renal Physiology 2004; 287: F999–F1010
   PubMed Web of Science ®Google Scholar